Bacterial keratitis.

GUIDELINE TITLE
Bacterial keratitis.

BIBLIOGRAPHIC SOURCE(S)
American Academy of Ophthalmology Cornea/External Disease Panel, Preferred Practice Patterns Committee. Bacterial keratitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 2008. 27 p. [109 references]

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: Cornea/External Disease Panel, Preferred Practice Patterns Committee. Bacterial keratitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 2005. 20 p.

All Preferred Practice Patterns are reviewed by their parent panel annually or earlier if developments warrant and updated accordingly. To ensure that all Preferred Practice Patterns are current, each is valid for 5 years from the "approved by" date unless superseded by a revision.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse (NGC): This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

July 08, 2008 – Fluoroquinolones (ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin): A BOXED WARNING and Medication Guide are to be added to the prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use.

ABRIR AQUÍ para acceder al documento NGC AHRQ completo:
Bacterial keratitis.